Physician profile
Lorie Fleck
NPI 1962487934
$26,278.36
in general payments reported to CMS, 2019-2025
46 companies · $1,614 in 2025
The $1,614 reported for 2025 was more than what 92% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,684 · 2020: $4,042 · 2021: $7,102 · 2022: $3,790 · 2023: $2,614 · 2024: $2,433 · 2025: $1,614.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,635 · Travel and Lodging: $26.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,634.88 |
| Travel and Lodging | $26.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $9,253.26 | 2019-2022 | |
| Medtronic, INC. | $3,996.25 | 2021-2025 | Interstim, Altaviva |
| Urovant Sciences INC | $2,011.08 | 2021-2022 | |
| Coloplast Corp | $1,998.62 | 2019-2025 | Speedicath |
| Abbvie INC. | $1,675.49 | 2019-2025 | |
| Axonics, INC. | $1,556.92 | 2020-2023 | Axonics |
| Astellas Pharma US INC | $693.60 | 2019-2022 | |
| Medtronic USA, INC. | $630.26 | 2019-2020 | |
| Valencia Technologies Corporation | $591.13 | 2022 | |
| Sumitomo Pharma America, INC. | $572.70 | 2023-2025 | Gemtesa, Orgovyx |
| Baxter Healthcare | $383.52 | 2020-2025 | Floseal, Perclot, Tisseel |
| Janssen Biotech, INC. | $381.86 | 2019-2025 | Erleada, Akeega |
| Endo Pharmaceuticals INC. | $296.36 | 2019-2024 | Xiaflex, Aveed, Edex |
| Boston Scientific Corporation | $196.54 | 2019-2024 | |
| Karl Storz Endoscopy-America | $186.18 | 2022-2023 | N.A. |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $155.41 | 2022-2025 | Jelmyto |
| Janssen Scientific Affairs, LLC | $142.81 | 2024 | Akeega, Erleada |
| Procept Biorobotics Corporation | $139.45 | 2023-2025 | Aquabeam System, Aquabeam Robotic System |
| Intuitive Surgical, INC. | $132.99 | 2025 | |
| Antares Pharma, INC. | $127.94 | 2022-2023 | Xyosted, Nocdurna, Tlando |
| Dendreon Pharmaceuticals LLC | $112.91 | 2019-2025 | Provenge |
| Teleflex LLC | $107.94 | 2025 | Urolift, Barrigel |
| Mission Pharmacal Company | $92.04 | 2019-2024 | Uribel, Uribel Tabs |
| Pfizer INC. | $88.31 | 2019-2022 | |
| Bluewind Medical | $82.20 | 2024 | Revi |
| C. R. Bard, INC. & Subsidiaries | $78.54 | 2020 | |
| Orthalign INC | $74.66 | 2025 | Orthalign Plus |
| Olympus America INC. | $70.85 | 2024 | Itind System |
| Accord Healthcare, INC. | $55.93 | 2022 | |
| Convatec INC. | $42.49 | 2022 | |
| Myovant Sciences INC. | $37.79 | 2022 | |
| Myriad Genetic Laboratories, INC. | $37.75 | 2023-2025 | Prolaris |
| Agiliti Surgical, INC. | $35.28 | 2019-2024 | Endocare Cryocare Cs System, Sonablate Hifu, Koelis Trinity Fusion Biopsy System |
| 180 Medical, INC. | $25.38 | 2025 | Gentlecath Glide |
| Endo USA, INC. | $24.61 | 2024 | Xiaflex |
| Novo Nordisk INC | $23.46 | 2024 | |
| Immunitybio, INC. | $23.37 | 2025 | |
| Astellas Pharma Global Development | $23.15 | 2019 | |
| Blue Earth Diagnostics | $17.18 | 2024 | |
| Alnylam Pharmaceuticals INC. | $16.51 | 2023 | Oxlumo |
| Bayer Healthcare Pharmaceuticals INC. | $16.26 | 2022 | |
| Travere Therapeutics, INC. | $15.61 | 2019 | |
| Ambu INC. | $15.32 | 2022 | |
| Ferring Pharmaceuticals INC. | $14.28 | 2019 | |
| Rochester Medical Corporation | $12.97 | 2019 | |
| Philips North America LLC | $11.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lorie Fleck listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.